<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlSource>
  <Section SecID="390" OrdBy="100" Name="General">
    <Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: clinical practice guidelines for cardiopulmonary bypass&amp;mdash;temperature management during cardiopulmonary bypass.&lt;/div&gt;" />
    </Field>
    <Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Engelman R, Baker RA, Likosky DS, Grigore A, Dickinson TA, Shore-Lesserson L, Hammon JW, Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists, American Society of ExtraCorporeal Technology. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: clinical practice guidelines for cardiopulmonary bypass--temperature management during cardiopulmonary bypass. Ann Thorac Surg. 2015 Aug;100(2):748-57. [55 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=26234862&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline meets NGC's 2013 (revised) inclusion criteria.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="420" OrdBy="300" Name="Recommendations">
    <Field FieldID="151" OrdBy="310" ID="421" Name="Major Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Definitions for the class of recommendations (&lt;strong&gt;I-III&lt;/strong&gt;) and the level of the evidence (&lt;strong&gt;A-C&lt;/strong&gt;) are provided at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Optimal Site for Temperature Measurement&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;The oxygenator arterial outlet blood temperature is recommended to be used as a surrogate for cerebral temperature measurement during cardiopulmonary bypass (CPB). (&lt;strong&gt;Class I, Level C&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To accurately monitor cerebral perfusate temperature during warming, it should be assumed that the oxygenator arterial outlet blood temperature underestimates cerebral perfusate temperature. (&lt;strong&gt;Class I, Level C&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pulmonary artery or nasopharyngeal (NP) temperature recording is reasonable for core temperature measurement. (&lt;strong&gt;Class IIa, Level C&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Avoidance of Hyperthermia&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Surgical teams should limit arterial outlet blood temperature to less than 37&amp;deg;C to avoid cerebral hyperthermia. (&lt;strong&gt;Class I, Level C&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Peak Cooling Temperature Gradient and Cooling Rate&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Temperature gradients between the arterial outlet and venous inflow on the oxygenator during CPB cooling should not exceed 10&amp;deg;C to avoid generation of gaseous emboli. (&lt;strong&gt;Class I, Level C&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Peak Warming Temperature Gradient and Rewarming Rate&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Temperature gradients between the arterial outlet and venous inflow on the oxygenator during CPB rewarming should not exceed 10&amp;deg;C to avoid outgassing when warm blood is returned to the patient. (&lt;strong&gt;Class I, Level C&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Rewarming when arterial blood outlet temperature &amp;ge;30&amp;deg;C:&#xD;&#xA;    &lt;ol style=&quot;list-style-type: lower-alpha;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;        &lt;li&gt;To achieve the desired temperature for separation from bypass, it is reasonable to maintain a temperature gradient between the arterial outlet and the venous inflow temperature of 4&amp;deg;C or less. (&lt;strong&gt;Class IIa, Level B&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;To achieve the desired temperature for separation from bypass, it is reasonable to maintain a rewarming rate of 0.5&amp;deg;C/min or less. (&lt;strong&gt;Class IIa, Level B&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;/ol&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Rewarming when arterial blood outlet temperature is lower than 30&amp;deg;C: To achieve the desired temperature for separation from bypass, it is reasonable to maintain a maximal gradient of 10&amp;deg;C between the arterial outlet and venous inflow temperature. (&lt;strong&gt;Class IIa, Level C&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Optimal Temperature for Weaning From CPB&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;No specific recommendation for an optimal temperature for weaning from CPB may be made due to inconsistent published evidence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;American College of Cardiology/American Heart Association: Classifications&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Cardiology/American Heart Association: Classifications&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Classification&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Clinical Recommendation&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class I&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Benefit &amp;gt;&amp;gt;&amp;gt; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class II&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment. This is classified as IIa or IIb.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class IIa&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Benefit &amp;gt;&amp;gt; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Weight of evidence/opinion is in favor of usefulness/efficacy.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class IIb&lt;/th&gt;&#xD;&#xA;            &lt;td style=&quot;vertical-align: top;&quot;&gt;Benefit &amp;ge; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Usefulness/efficacy is less well established by evidence/opinion.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class III&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Risk &amp;ge; Benefit&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful. This is defined as: No Benefit - Procedure/test not helpful or treatment without established proven benefit; Harm - Procedure/test/treatment leads to excess cost without benefit or is harmful.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;American College of Cardiology/American Heart Association: Level of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Cardiology/American Heart Association: Level of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;col&quot;&gt;Level of Evidence&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;col&quot;&gt;Type of Evidence&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from multiple randomized trials or meta-analyses&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from single randomized trial or non-randomized studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from expert opinion, case studies, or standard-of-care&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="138" OrdBy="330" ID="423" Name="Clinical Algorithm(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="396" OrdBy="400" Name="Scope">
    <Field FieldID="140" OrdBy="405" ID="397" Name="Disease/Condition(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Diseases or conditions requiring cardiopulmonary bypass (CPB)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="103" OrdBy="410" ID="398" Name="Guideline Category" Type="picklist-many">
      <FieldValue Value="Assessment of Therapeutic Effectiveness" />
      <FieldValue Value="Management" />
      <FieldValue Value="Treatment" />
    </Field>
    <Field FieldID="113" OrdBy="415" ID="399" Name="Clinical Specialty" Type="picklist-many">
      <FieldValue Value="Anesthesiology" />
      <FieldValue Value="Cardiology" />
      <FieldValue Value="Thoracic Surgery" />
    </Field>
    <Field FieldID="114" OrdBy="420" ID="400" Name="Intended Users" Type="picklist-many">
      <FieldValue Value="Advanced Practice Nurses" />
      <FieldValue Value="Physician Assistants" />
      <FieldValue Value="Physicians" />
    </Field>
    <Field FieldID="129" OrdBy="425" ID="401" Name="Guideline Objective(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To provide evidence-based recommendations supporting temperature management during cardiopulmonary bypass (CPB)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="132" OrdBy="430" ID="402" Name="Target Population" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Patients undergoing cardiopulmonary bypass (CPB)&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="133" OrdBy="435" ID="403" Name="Interventions and Practices Considered" Type="text">
      <FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Site for temperature measurement&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Oxygenator arterial outlet blood temperature &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Pulmonary artery or nasopharyngeal temperature (for core temperature measurement) &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Avoidance of hyperthermia (arterial outlet blood temperature less than 37&amp;deg;C) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of peak cooling temperature gradient and cooling rate &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of peak warming temperature gradient and rewarming rate &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: Optimal temperature for weaning from cardiopulmonary bypass (CPB) was considered but not recommended.&lt;/p&gt;" />
    </Field>
    <Field FieldID="134" OrdBy="440" ID="404" Name="Major Outcomes Considered" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Neurocognitive function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cardiac performance &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Jugular venous oxygen hemoglobin saturation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Morbidity/mortality &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Transfusion rate &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Intensive care unit stay &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
  </Section>
  <Section SecID="405" OrdBy="500" Name="Methodology">
    <Field FieldID="109" OrdBy="505" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many">
      <FieldValue Value="Searches of Electronic Databases" />
    </Field>
    <Field FieldID="135" OrdBy="510" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Literature Search&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The guideline developers used a systematic search of Medical Subject Heading (MeSH) terms to identify peer-reviewed articles related to temperature management in the setting of adult cardiopulmonary bypass (CPB). Candidate articles were published in PubMed between January 1, 2000, and March 31, 2014. The search revealed 768 abstracts, all of which were reviewed in duplicate by independent reviewers, with 153 abstracts selected for full paper review. To be included, each paper had to report data on each of the following: (1) optimal site for temperature monitoring, (2) avoidance of hyperthermia, (3) peak cooling temperature gradient and cooling rate, and (4) peak warming temperature gradient and rewarming rate.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;According to American College of Cardiology/American Heart Association (ACC/AHA) rules, any reviewer could select an abstract for inclusion in a paper review, but at least 2 reviewers had to agree to exclude a paper. At the paper review stage, at least 2 reviewers had to agree to exclude a paper. These rules were incorporated into Guideliner reviewing software.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;MeSH terms used to identify peer-reviewed articles related to temperature management in the setting of adult cardiopulmonary bypass:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;(&quot;cardiopulmonary bypass&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; perfusion [TIAB]) &lt;em&gt;and&lt;/em&gt; (&quot;body temperature&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; &quot;body temperature regulation&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; &quot;rewarming&quot; [MeSH Terms]) &lt;em&gt;and&lt;/em&gt; (&quot;humans&quot; [MeSH Terms] &lt;em&gt;and&lt;/em&gt; English [lang] &lt;em&gt;and&lt;/em&gt; &quot;adult&quot; [MeSH Terms])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;((&quot;cardiopulmonary bypass&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; cardiopulmonarybypass [TIAB]) &lt;em&gt;and&lt;/em&gt; (&quot;hypothermia, induced/instrumentation&quot; [MAJR:noexp] &lt;em&gt;or&lt;/em&gt; &quot;hypothermia, induced/methods&quot; [MAJR:noexp] &lt;em&gt;or&lt;/em&gt; &quot;body temperature&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; &quot;body temperature regulation&quot; [MeSH Terms] &lt;em&gt;or &lt;/em&gt;&quot;rewarming&quot; [MeSH Terms]) &lt;em&gt;and&lt;/em&gt; (&quot;humans&quot; [MeSH Terms] &lt;em&gt;and&lt;/em&gt; English [lang])) &lt;em&gt;not&lt;/em&gt; ((&quot;cardiopulmonary bypass&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; perfusion [TIAB]) &lt;em&gt;and&lt;/em&gt; (&quot;body temperature&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; &quot;body temperature regulation&quot; [MeSH Terms] &lt;em&gt;or&lt;/em&gt; &quot;rewarming&quot; [MeSH Terms]) &lt;em&gt;and&lt;/em&gt; (&quot;humans&quot; [MeSH Terms] &lt;em&gt;and&lt;/em&gt; English [lang] &lt;em&gt;and&lt;/em&gt; &quot;adult&quot; [MeSH Terms])).&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="136" OrdBy="515" ID="408" Name="Number of Source Documents" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Two reviewers rejected 615 abstracts based on a lack of relevance, leaving 153 abstracts for full paper review. Two panel members reviewed each paper, and 82 of these papers were found not to contribute to the topic by both reviewers, a further 32 had conflicting reviews and were individually resolved, and the final 39 were considered for inclusion in the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Thirteen articles considered relevant to the topic by the authors were included to provide method, context, or additional supporting evidence for the recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See Figure 1 in the original guideline document for a flowchart of study selection.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="115" OrdBy="520" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice">
      <FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" />
    </Field>
    <Field FieldID="149" OrdBy="525" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;American College of Cardiology/American Heart Association: Level of Evidence&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Cardiology/American Heart Association: Level of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;col&quot;&gt;Level of Evidence&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;col&quot;&gt;Type of Evidence&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from multiple randomized trials or meta-analyses&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from single randomized trial or non-randomized studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Level C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence from expert opinion, case studies, or standard-of-care&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="116" OrdBy="530" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many">
      <FieldValue Value="Systematic Review with Evidence Tables" />
    </Field>
    <Field FieldID="150" OrdBy="535" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="112" OrdBy="540" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice">
      <FieldValue Value="Not stated" />
    </Field>
    <Field FieldID="145" OrdBy="545" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="146" OrdBy="550" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;American College of Cardiology/American Heart Association: Classifications&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: American College of Cardiology/American Heart Association: Classifications&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Classification&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Clinical Recommendation&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class I&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Benefit &amp;gt;&amp;gt;&amp;gt; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class II&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment. This is classified as IIa or IIb.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class IIa&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Benefit &amp;gt;&amp;gt; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Weight of evidence/opinion is in favor of usefulness/efficacy.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class IIb&lt;/th&gt;&#xD;&#xA;            &lt;td style=&quot;vertical-align: top;&quot;&gt;Benefit &amp;ge; Risk&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Usefulness/efficacy is less well established by evidence/opinion.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; scope=&quot;row&quot;&gt;Class III&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Risk &amp;ge; Benefit&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful. This is defined as: No Benefit - Procedure/test not helpful or treatment without established proven benefit; Harm - Procedure/test/treatment leads to excess cost without benefit or is harmful.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="148" OrdBy="565" ID="417" Name="Cost Analysis" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="104" OrdBy="570" ID="418" Name="Method of Guideline Validation" Type="picklist-choice">
      <FieldValue Value="Not stated" />
    </Field>
    <Field FieldID="130" OrdBy="575" ID="419" Name="Description of Method of Guideline Validation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations">
    <Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations">
    <Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Avoidance of cerebral hyperthermia in the setting of cardiopulmonary bypass (CPB) has been promoted to avoid cerebral injury. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Avoidance of adverse effects associated with hyperthermia. One study reported an association with hyperthermia and an increased rate of mediastinitis. Another study reported that an arterial outlet temperature exceeding 37&amp;deg;C during CPB is an independent predictor of acute kidney injury. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Outgassing may be prevented by maintaining a maximal 10&amp;deg;C gradient between the arterial blood outlet and the venous inlet blood temperature. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;According to one author, slow rewarming increases the likelihood of preventing hyperthermia. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
    <Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Slowest rewarming rate was associated with improved indices of cardiac function (improved cardiac index and decreased lactate production) but was disadvantaged by longer bypass times and time to reach core temperature targets. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The data suggest that rapid rewarming to normothermia may lead to inadvertent cerebral hyperthermia. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
  </Section>
  <Section SecID="432" OrdBy="900" Name="Qualifying Statements">
    <Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Temperature management during cardiopulmonary bypass (CPB) remains controversial, with gaps in knowledge concerning a variety of aspects of temperature management. The Institute of Medicine has identified the need to incorporate the best clinical evidence into practice. Importantly, these guidelines challenge the cardiac surgical community to conduct research to address these gaps in knowledge.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline">
    <Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many">
      <FieldValue Value="Getting Better" />
    </Field>
    <Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many">
      <FieldValue Value="Patient-centeredness" />
    </Field>
  </Section>
  <Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability">
    <Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Engelman R, Baker RA, Likosky DS, Grigore A, Dickinson TA, Shore-Lesserson L, Hammon JW, Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists, American Society of ExtraCorporeal Technology. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: clinical practice guidelines for cardiopulmonary bypass--temperature management during cardiopulmonary bypass. Ann Thorac Surg. 2015 Aug;100(2):748-57. [55 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=26234862&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text">
      <FieldValue Value="2015 Aug" />
    </Field>
    <Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p">
      <FieldValue Value="American Society of Extra-Corporeal Technology - Nonprofit Organization" />
      <FieldValue Value="Society of Cardiovascular Anesthesiologists - Medical Specialty Society" />
      <FieldValue Value="Society of Thoracic Surgeons - Medical Specialty Society" />
    </Field>
    <Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Society of Thoracic Surgeons&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Authors&lt;/em&gt;: Richard Engelman, MD, Department of Surgery, Baystate Medical Center and Tufts University School of Medicine, Springfield, Massachusetts; Robert A. Baker, PhD, CCP, Cardiac Surgery Research and Perfusion, Flinders University and Flinders Medical Centre, Adelaide, South Australia, Australia; Donald S. Likosky, PhD, Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan; Alina Grigore, MD, Department of Anesthesiology, University of Nevada, Las Vegas, Nevada; Timothy A. Dickinson, MS, Clinical Performance Improvement, SpecialtyCare, Nashville, Tennessee; Linda Shore-Lesserson, MD, Department of Anesthesiology, Hofstra Northshore-Long Island Jewish School of Medicine, New Hyde Park, New York; John W. Hammon, MD, Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline meets NGC's 2013 (revised) inclusion criteria.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Available from the &lt;a href=&quot;http://www.sts.org/sites/default/files/documents/pdf/guidelines/Guidelines_CPB%20Temperature%20Management.pdf&quot; title=&quot;Society of Thoracic Surgeons Web site&quot;&gt;Society of Thoracic Surgeons Web site&lt;/a&gt;. &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on May 6, 2016.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&amp;copy; 2015 by The Society of Thoracic Surgeons&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Society of Thoracic Surgeons Practice Guidelines may be printed or downloaded for individual and personal use only. Guidelines may not be reproduced in any print or electronic publication or offered for sale or distribution in any format without the express written permission of the Society of Thoracic Surgeons.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Guideline Clearinghouseâ¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NGC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>